Protagenic Therapeutics, Inc.\new (PTIX) Latest Filing Signal

Latest Filing: 10-Q  |  Filed Mar 9, 2026

Cross-checked across multiple AI analysts and grounded in the latest SEC filing.

powered by: earningsVibe.ai

Question:
What is the latest filing signal for Protagenic Therapeutics, Inc.\new?
Answer:
Based on earningsVibe SuperAnalyst™ synthesis of the latest 10-Q, Protagenic Therapeutics, Inc.\new's filing signal turned negative.
earningsVibe SuperAnalyst™ Verdict: TURNED NEGATIVE

Signal Performance — Stock Price Since Filing

30-Day Change
+63.90%
from filing date
60-Day Change
Pending
from filing date

Underlying analyst views from Perplexity, Gemini, Claude, and ChatGPT

PERPLEXITY
Continuing Negative
GEMINI
Turned Negative
CLAUDE
Turned Negative
CHATGPT
Turned Negative

Unlock the Full Filing Analysis

See full earningsSig™ and risksSig™ analysis across 5,000+ companies

Get Started Free →

No credit card required

Question:
What does Protagenic Therapeutics, Inc.\new actually do?
Answer:
Protagenic Therapeutics, Inc. is a biopharmaceutical company focused on discovering and developing therapeutics for stress-related neuropsychiatric and mood disorders. Its lead compound, PT00114, a synthetic form of the endogenous brain signaling peptide TCAP, targets depression, anxiety, substance abuse, and PTSD by dampening overactive stress responses through a novel mechanism of action. The company has initiated Phase I human trials for PT00114 and anticipates reporting Phase II efficacy results in early 2026. Protagenic Therapeutics holds exclusive worldwide rights to PT00114 and is also engaged in developing follow-on compounds within the TCAP family.
Question:
What are Protagenic Therapeutics, Inc.\new's revenue drivers?
Answer:
The company has not yet generated revenue from product sales and anticipates that revenue generation will not occur for several years, contingent on successful clinical trials and regulatory approvals. Future revenue may be sought through collaboration or licensing agreements.

Cut through noisy SEC filings to find the signal faster

Source-grounded filing intelligence with one-click links back to the filing, so you can move faster and verify everything at the source.

Get Started Free →

No credit card required